APA (7th ed.) Citation

Ritterhoff, J., Völkers, M., Seitz, A., Spaich, K., Pleger, S. T., Fink, R., . . . Most, P. (2015). S100A1 DNA-based inotropic therapy protects against proarrhythmogenic ryanodine receptor 2 dysfunction. Molecular therapy, 23(8), . https://doi.org/10.1038/mt.2015.93

Chicago Style (17th ed.) Citation

Ritterhoff, Julia, Mirko Völkers, Andreas Seitz, Kristin Spaich, Sven Torsten Pleger, Rainer Fink, Hugo Katus, and Patrick Most. "S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction." Molecular Therapy 23, no. 8 (2015). https://doi.org/10.1038/mt.2015.93.

MLA (9th ed.) Citation

Ritterhoff, Julia, et al. "S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction." Molecular Therapy, vol. 23, no. 8, 2015, https://doi.org/10.1038/mt.2015.93.